Galectin Therapeutics Inc.
GALT
Last
$3.94
Day
+8.2%
1y
-23.4%
5y
-1.4%
52w
-48.9%
SPY YTD
+13.3%
XLV
+8.1%
Earnings
2026-11-1333d
EMA 21
3.82
EMA 50
3.78
EMA 200
3.49
20d high
-14.2%
5y high
-48.9%
5y range
46th
Positions held
Your positionsGALT isn't in your positions.
Add it to see shares, cost, and P&L here.
Score
17
Hold
watch
Signal
Neutral
Target
$4.29
Stop
$3.32
Stop distance
15.7%
Target vs last
+8.9%
Fundamentals
| Market cap | $367.09M | Enterprise value | $499.98M | Trailing P/E | — | Forward P/E | -2.17 |
| PEG | -36.15 | Price / book | -1.74 | Beta | 0.38 | Dividend yield | 0.00% |
| Revenue growth | — | Earnings growth | — | Gross margin | 0.0% | Operating margin | 0.0% |
| Profit margin | 0.0% | ROE | — | ROA | -64.2% | Debt / equity | — |
| Current ratio | 0.10 | Free cash flow | -$14.86M | Analyst recommendation | none | Mean target | $11.00 |
| 52w high | $7.13 | 52w low | $2.03 |
Quarterly
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | |
|---|---|---|---|---|---|---|
| Revenue | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | — |
| Op margin | — | — | — | — | — | — |
| Net income | -$9.1M | -$5.0M | -$5.5M | -$8.2M | -$7.5M | — |
| Gross margin | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — |
| Operating income | -$4.0M | -$4.1M | -$3.4M | -$4.2M | -$4.6M | — |
Yearly (6y)
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Revenue | $0.0M | $0.0M | $0.0M | $0.0M |
| Op margin | — | — | — | — |
| Net income | -$30.8M | -$47.0M | -$41.1M | -$38.8M |
| Gross margin | — | — | — | — |
| Gross profit | — | — | — | — |
| Operating income | -$20.1M | -$42.4M | -$38.1M | -$38.4M |
Headline scan
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
Price (daily)
Full chart · RSI · MACD · patternsGALT · daily-12.1% over 13 sessions
Close EMA21 EMA50 EMA200
Quarterly · revenue, net income, margins
Revenue Net income Gross margin Op margin